Prevalence, Risk Factors and Vaccine Response against Hepatitis B in People Aged 50 Years or Older.
Luana Rocha da Cunha RosaLeyla Gabriela Verner Amaral BrandãoWinny Éveny Alves MouraLays Rosa CamposGrécia Carolina PessoniJuliana de Oliveira Roque E LimaJosé Cássio de MoraesMegmar Aparecida Dos Santos CarneiroSheila Araujo TelesKarlla Antonieta Amorim CaetanoPublished in: Vaccines (2023)
reinforced doses should be used in individuals aged 50 years or older to overcome the lower efficacy of the vaccine against hepatitis B.